Advanced non-small-cell lung cancer: adjunctive interferon gamma in induction and maintenance therapy.
Journal of cancer research and clinical oncology(1999)
摘要
In patients with advanced NSCLC, an adjunctive dose of 100 microg IFNgamma, given three times weekly in the induction and maintenance phase, is feasible. Survival data seem favourable so this regimen may warrant further investigation in a phase III study.
更多查看译文
关键词
non-small-cell lung cancer,chemotherapy interferon gamma,phase II study
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要